PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.31%
Negative revenue growth while INTC stands at 3.27%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
2.08%
Positive gross profit growth while INTC is negative. John Neff would see a clear operational edge over the competitor.
24.74%
Positive EBIT growth while INTC is negative. John Neff might see a substantial edge in operational management.
24.74%
Positive operating income growth while INTC is negative. John Neff might view this as a competitive edge in operations.
587.55%
Positive net income growth while INTC is negative. John Neff might see a big relative performance advantage.
558.82%
Positive EPS growth while INTC is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
568.75%
Positive diluted EPS growth while INTC is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.89%
Share change of 0.89% while INTC is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.76%
Diluted share change of 0.76% while INTC is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-3.88%
Dividend reduction while INTC stands at 19.51%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.44%
Negative OCF growth while INTC is at 25.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-26.97%
Negative FCF growth while INTC is at 31.74%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
41.78%
10Y revenue/share CAGR under 50% of INTC's 881.00%. Michael Burry would suspect a lasting competitive disadvantage.
2.59%
5Y revenue/share CAGR under 50% of INTC's 297.25%. Michael Burry would suspect a significant competitive gap or product weakness.
-7.06%
Negative 3Y CAGR while INTC stands at 128.26%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
37.89%
Below 50% of INTC's 710.71%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.84%
3Y OCF/share CAGR under 50% of INTC's 420.05%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2355.49%
10Y net income/share CAGR of 2355.49% while INTC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2232.04%
5Y net income/share CAGR above 1.5x INTC's 501.68%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
780.74%
3Y net income/share CAGR above 1.5x INTC's 153.60%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
146.09%
5Y equity/share CAGR at 50-75% of INTC's 261.63%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
111.23%
3Y equity/share CAGR at 75-90% of INTC's 133.96%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
84.04%
Dividend/share CAGR of 84.04% while INTC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
8.03%
Dividend/share CAGR of 8.03% while INTC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
39.18%
Below 50% of INTC's 108.11%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-0.17%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.85%
Inventory growth well above INTC's 4.44%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.62%
Asset growth above 1.5x INTC's 8.17%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
40.37%
BV/share growth above 1.5x INTC's 14.59%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.41%
We’re deleveraging while INTC stands at 5.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-1.79%
Our R&D shrinks while INTC invests at 1.91%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.